[Basic study on human lymphoblastoid interferon-alpha (MOR-22): Part I. Antiviral effect].

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Human interferon-alpha (IFN-alpha), specifically MOR-22 produced by the BALL-1 cell line, is a key antiviral protein.
• Understanding the broadness of its antiviral spectrum and the underlying molecular mechanisms is crucial for therapeutic applications.

Purpose of the Study:

• To evaluate the antiviral efficacy of human interferon-alpha (MOR-22) against a panel of DNA and RNA viruses.
• To investigate the role of 2',5'-oligo A synthetase induction in the antiviral mechanism of IFN-alpha.

Main Methods:

• Antiviral activity testing of IFN-alpha (MOR-22) against 4 DNA and 9 RNA viruses.
• Determination of IC90 values (the concentration required to inhibit viral activity by 90%).
• Assay of 2',5'-oligo A synthetase activity induction in various cell lines (RSa, HeLa S3, M08, HEC-IC).

Main Results:

• IFN-alpha (MOR-22) exhibited significant inhibition against all tested viruses, with IC90s ranging from 10(1) to 10(4) IU/ml.
• The study confirmed a very wide antiviral spectrum for IFN-alpha.
• IFN-alpha successfully induced 2',5'-oligo A synthetase activity in RSa, HeLa S3, and M08 cells, but not in HEC-IC cells, which lack IFN-alpha receptors.

Conclusions:

• Human interferon-alpha (MOR-22) possesses broad-spectrum antiviral properties.
• The induction of 2',5'-oligo A synthetase activity via the IFN-alpha receptor is strongly suggested as a primary antiviral mechanism.